company background image
APLLTD logo

Alembic Pharmaceuticals NSEI:APLLTD Rapporto sulle azioni

Ultimo prezzo

₹1.04k

Cap. di mercato

₹204.8b

7D

1.3%

1Y

43.6%

Aggiornato

24 Nov, 2024

Dati

Dati finanziari dell'azienda +

Alembic Pharmaceuticals Limited

NSEI:APLLTD Rapporto sulle azioni

Cap. di mercato: ₹204.8b

APLLTD Panoramica delle azioni

Alembic Pharmaceuticals Limited sviluppa, produce e commercializza prodotti farmaceutici in India e a livello internazionale. Maggiori dettagli

APLLTD analisi fondamentale
Punteggio fiocco di neve
Valutazione2/6
Crescita futura4/6
Prestazioni passate4/6
Salute finanziaria6/6
Dividendi3/6

Alembic Pharmaceuticals Limited Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Alembic Pharmaceuticals
Prezzi storici delle azioni
Prezzo attuale dell'azione₹1,041.85
Massimo di 52 settimane₹1,303.90
Minimo di 52 settimane₹714.75
Beta0.69
1Variazione di 1 mese-2.44%
Variazione a 3 mesi-4.90%
Variazione di 1 anno43.61%
3Variazione a 3 anni30.79%
Variazione a 5 anni88.78%
Variazione dall'IPO2,081.88%

Notizie e aggiornamenti recenti

Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts

Nov 10
Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts

Recent updates

Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts

Nov 10
Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts

Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Sep 25
Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Sep 03
Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 13
Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Jul 20
Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Jun 03
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

May 11
Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 08
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Jan 21
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Jan 05
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Sep 27
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

Jun 09
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Apr 13
A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Feb 22
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jan 04
Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Nov 05
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Aug 10
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Jul 20
Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Rendimenti per gli azionisti

APLLTDIN PharmaceuticalsIN Mercato
7D1.3%0.5%0.5%
1Y43.6%42.5%27.5%

Ritorno vs Industria: APLLTD ha superato il Indian Pharmaceuticals che ha restituito 42.5 % nell'ultimo anno.

Rendimento vs Mercato: APLLTD ha superato il mercato Indian che ha restituito 27.5 % nell'ultimo anno.

Volatilità dei prezzi

Is APLLTD's price volatile compared to industry and market?
APLLTD volatility
APLLTD Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Prezzo delle azioni stabile: APLLTD non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 6% ) di APLLTD è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
190714,858Chirayu Aminalembicpharmaceuticals.com

Alembic Pharmaceuticals Limited sviluppa, produce e commercializza prodotti farmaceutici in India e a livello internazionale. L'azienda fornisce specialità medicinali di marca in varie aree terapeutiche, quali cardiologia, ginecologia, gastrologia, oftalmologia, dermatologia, nefrologia/urologia, ortopedia, antinfettivi, raffreddore e tosse, veterinaria e antidiabetici; formulazioni generiche in solidi orali, solidi orali e iniettabili per oncologia, iniettabili generici e prodotti oftalmici, dermatologia e sospensione orale; e ingredienti farmaceutici attivi. L'azienda esporta anche i suoi prodotti.

Alembic Pharmaceuticals Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Alembic Pharmaceuticals con la sua capitalizzazione di mercato?
APLLTD statistiche fondamentali
Capitalizzazione di mercato₹204.79b
Guadagni(TTM)₹6.47b
Ricavi(TTM)₹63.57b

31.7x

Rapporto P/E

3.2x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
APLLTD Conto economico (TTM)
Ricavi₹63.57b
Costo del fatturato₹17.44b
Profitto lordo₹46.13b
Altre spese₹39.66b
Guadagni₹6.47b

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)32.90
Margine lordo72.56%
Margine di profitto netto10.17%
Rapporto debito/patrimonio netto20.4%

Come si è comportato APLLTD nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.1%

Rendimento attuale del dividendo

35%

Rapporto di remunerazione